The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
New Equations to Estimate GFR in Children with CKD
Schwartz, G. J., Mun[Combining Tilde]oz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030287 · Cited by 3,777
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
Correction of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
MacLeod, A. M. (2009) · Kidney International · Cited by 2,218
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,104
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Going from evidence to recommendations
Guyatt, G. H., Oxman, A. D., Kunz, R., Falck-Ytter, Y., Vist, G. E., Liberati, A., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39493.646875.ae · Cited by 1,810
Clinical diagnosis and management by laboratory methods
Henry, J. B. (1979) · Medical Entomology and Zoology · Cited by 1,691
Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia.
de Benoist, B., McLean, E., Egll, I., & Cogswell, M. E. (2008) · Cited by 1,543
(2003) · Quality and Safety in Health Care · doi:10.1136/qhc.12.1.18 · Cited by 1,446
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
Carson, J. L., Grossman, B. J., Kleinman, S., Tinmouth, A. T., Marques, M. B., Fung, M. K., Holcomb, J. B., Illoh, O., Kaplan, L. J., Katz, L. M., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-1-201206190-00429 · Cited by 1,084
Finding What Works in Health Care: Standards for Systematic Reviews
Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 942
A Clinical Evaluation of Serum Ferritin as an Index of Iron Stores
Lipschitz, D. A., Cook, J. D., & Finch, C. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197405302902201 · Cited by 938
Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
Levin, A., Thompson, C. R., Ethier, J., Carlisle, E. J. F., Tobe, S., Mendelssohn, D., Burgess, E., Jindal, K., Barrett, B., Singer, J., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70118-6 · Cited by 841
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.010 · Cited by 829
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
Port, F. K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510110079036 · Cited by 825
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Lefaucheur, C., Loupy, A., Hill, G. S., Andrade, J., Nochy, D., Antoine, C., Gautreau, C., Charron, D., Glotz, D., & Suberbielle-Boissel, C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101065 · Cited by 789
Locatelli, F. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1032 · Cited by 785
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 769
Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Burton, P. B. J., Murphy, S. A., McCabe, C. H., Gibson, C. M., & Braunwald, E. (2005) · Circulation · doi:10.1161/01.cir.0000162477.70955.5f · Cited by 745
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.008 · Cited by 727
Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
Harnett, J. D., Foley, R. N., Kent, G. M., Barre, P. E., Murray, D., & Parfrey, P. S. (1995) · Kidney International · doi:10.1038/ki.1995.132 · Cited by 719
Astor, B. C., Muntner, P., Levin, A., Eustace, J. A., & Coresh, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.12.1401 · Cited by 716
Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel
Kleinman, S., Caulfield, T., Chan, P., Davenport, R., McFarland, J., McPhedran, S., Meade, M., Morrison, D., Pinsent, T., Robillard, P., et al. (2004) · Transfusion · doi:10.1111/j.0041-1132.2004.04347.x · Cited by 712
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
Szczech, L. A., Barnhart, H. X., Inrig, J. K., Reddan, D. N., Sapp, S., Califf, R. M., Patel, U. D., & Singh, A. K. (2008) · Kidney International · doi:10.1038/ki.2008.295 · Cited by 526
Hoen, B., Paul-Dauphin, A., Hestin, D., & Kessler, M. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v95869 · Cited by 514
Transfusion-related acute lung injury
Silliman, C. C., Ambruso, D. R., & Boshkov, L. K. (2005) · Blood · doi:10.1182/blood-2004-07-2929 · Cited by 491
Red blood cell transfusion in clinical practice
Klein, H. G., Spahn, D. R., & Carson, J. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61197-0 · Cited by 487
Iron Homeostasis and the Inflammatory Response
Wessling-Resnick, M. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104804 · Cited by 480
Erythropoietic response and outcomes in kidney disease and type 2 diabetes
Solomon, S. D., Uno, H., Lewis, E. F., Eckardt, K.-U., Lin, J., Burdmann, E. A., de Zeeuw, D., Ivanovich, P., Levey, A. S., Parfrey, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005109 · Cited by 473
Update on adverse drug events associated with parenteral iron
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi253 · Cited by 457
Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial
Terasaki, P. I., & Ozawa, M. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00360.x · Cited by 453
Shiffman, R. N., Shekelle, P., Overhage, J. M., Slutsky, J., Grimshaw, J., & Deshpande, A. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00013 · Cited by 451
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
Lu, M., Cohen, M. H., Rieves, D., & Pazdur, R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21656 · Cited by 443
Emerging infectious disease agents and their potential threat to transfusion safety
Stramer, S. L., Hollinger, F. B., Katz, L. M., Kleinman, S., Metzel, P. S., Gregory, K. R., & Dodd, R. Y. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02279.x · Cited by 427
A randomized controlled study of iron supplementation in patients treated with erythropoietin
Macdougall, I. C., Tucker, B., Thompson, J., Tomson, C. R. V., Baker, L. R. I., & Raine, A. E. G. (1996) · Kidney International · doi:10.1038/ki.1996.487 · Cited by 417
Regidor, D. L., Kopple, J. D., Kovesdy, C. P., Kilpatrick, R. D., McAllister, C. J., Aronovitz, J., Greenland, S., & Kalantar-Zadeh, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090997 · Cited by 408
Guidelines for the clinical use of red cell transfusions
(2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02701.x · Cited by 402
Coyne, D. W., Kapoian, T., Suki, W., Singh, A. K., Moran, J. E., Dahl, N. V., & Rizkala, A. R. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091034 · Cited by 391
Transfusion‐transmitted bacterial infectionin the United States, 1998 through 2000
Kuehnert, M. J., Roth, V. R., Haley, N. R., Gregory, K. R., Elder, K. V., Schreiber, G. B., Arduino, M. J., Holt, S. C., Carson, L. A., Banerjee, S. N., et al. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41121493.x · Cited by 378
Fishbane, S., Frei, G. L., & Maesaka, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90151-5 · Cited by 377
Parfrey, P. S., Foley, R. N., Wittreich, B. H., Sullivan, D. J., Zagari, M. J., & Frei, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121039 · Cited by 373
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
Palmer, S. C., Navaneethan, S. D., Craig, J. C., Johnson, D. W., Tonelli, M., Garg, A. X., Pellegrini, F., Ravani, P., Jardine, M., Perkovic, V., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00252 · Cited by 363
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Bernhardt, W. M., Wiesener, M. S., Scigalla, P., Chou, J., Schmieder, R. E., Günzler, V., & Eckardt, K.-U. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010116 · Cited by 340
Shepshelovich, D., Rozen-Zvi, B., Avni, T., Gafter, U., & Gafter-Gvili, A. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.04.018 · Cited by 322
Byrd, T. F., & Horwitz, M. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114038 · Cited by 320
Rizzo, J. D., Brouwers, M., Hurley, P., Seidenfeld, J., Arcasoy, M. O., Spivak, J. L., Bennett, C. L., Bohlius, J., Evanchuk, D., Goode, M. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2201 · Cited by 303
Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis
Kaufman, J. S., Reda, D. J., Fye, C. L., Goldfarb, D. S., Henderson, W. G., Kleinman, J. G., & Vaamonde, C. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390902 · Cited by 300
Transfusion medicine: looking to the future
Goodnough, L. T., Shander, A., & Brecher, M. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12195-2 · Cited by 291
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
Fishbane, S., & Berns, J. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00532.x · Cited by 289
Rigatto, C., Parfrey, P., Foley, R., Negrijn, C., Tribula, C., & Jeffery, J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341084 · Cited by 274
Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients
BESARAB, A., AMIN, N., AHSAN, M., VOGEL, S. E., ZAZUWA, G., FRINAK, S., ZAZRA, J. J., ANANDAN, J. V., & GUPTA, A. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113530 · Cited by 273
The safety of intravenous iron dextran in hemodialysis patients
Fishbane, S., Ungureanu, V.-D., Maesaka, J. K., Kaupke, C. J., Lim, V., & Wish, J. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90463-1 · Cited by 272
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Spinowitz, B. S., Kausz, A. T., Baptista, J., Noble, S. D., Sothinathan, R., Bernardo, M. V., Brenner, L., & Pereira, B. J. G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101156 · Cited by 262
Revicki, D. A., Brown, R. E., Feeny, D. H., Henry, D., Teehan, B. P., Rudnick, M. R., & Benz, R. L. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90122-1 · Cited by 254
Boven, K., Stryker, S., Knight, J., Thomas, A., van Regenmortel, M., Kemeny, D. M., Power, D., Rossert, J., & Casadevall, N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00340.x · Cited by 251
PROSPECTIVE EVALUATION OF PRETRANSPLANT BLOOD TRANSFUSIONS IN CADAVER KIDNEY RECIPIENTS
Opelz, G., Vanrenterghem, Y., Kirste, G., Gray, D. W. R., Horsburgh, T., Lachance, J.-G., Largiader, F., Lange, H., Vujaklija-Stipanovic, K., Alvarez-Grande, J., et al. (1997) · Transplantation · doi:10.1097/00007890-199704150-00010 · Cited by 248
Transfusion-Related Acute Lung Injury
Looney, M. R., Gropper, M. A., & Matthay, M. A. (2004) · Chest · doi:10.1378/chest.126.1.249 · Cited by 229
Van Wyck, D. B., Roppolo, M., Martinez, C. O., Mazey, R. M., & Mcmurray, S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00758.x · Cited by 226
Furuland, H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.2.353 · Cited by 224
The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients
Ofsthun, N., Labrecque, J., Lacson, E., Keen, M., & Lazarus, J. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00937.x · Cited by 220
Locatelli, F., Covic, A., Eckardt, K.-U., Wiecek, A., Vanholder, R., & on behalf of the ERA-EDTA ERBP Advisory Board (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn653 · Cited by 218
Nissenson, A. R., Swan, S. K., Lindberg, J. S., Soroka, S. D., Beatey, R., Wang, C., Picarello, N., McDermott-Vitak, A., & Maroni, B. J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33919 · Cited by 211
Hemoglobin Variability and Mortality in ESRD
Yang, W., Israni, R. K., Brunelli, S. M., Joffe, M. M., Fishbane, S., & Feldman, H. I. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010058 · Cited by 211
Tessitore, N., Solero, G. P., Lippi, G., Bassi, A., Faccini, G. B., Bedogna, V., Gammaro, L., Brocco, G., Restivo, G., Bernich, P., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1416 · Cited by 210
Rizzo, J. D., Brouwers, M., Hurley, P., Seidenfeld, J., Arcasoy, M. O., Spivak, J. L., Bennett, C. L., Bohlius, J., Evanchuk, D., Goode, M. J., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300541 · Cited by 208
Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
Kilpatrick, R. D., Critchlow, C. W., Fishbane, S., Besarab, A., Stehman-Breen, C., Krishnan, M., & Bradbury, B. D. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04601007 · Cited by 206
Michael, B., Coyne, D. W., Fishbane, S., Folkert, V., Lynn, R., Nissenson, A. R., Agarwal, R., Eschbach, J. W., Fadem, S. Z., Trout, J. R., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00314.x · Cited by 199
Administration of Parenteral Iron and Mortality among Hemodialysis Patients
Feldman, H. I., Joffe, M., Robinson, B., Knauss, J., Cizman, B., Guo, W., Franklin-Becker, E., & Faich, G. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128009.69594.be · Cited by 192
Hollowell, J. G., van Assendelft, O. W., Gunter, E. W., Lewis, B. G., Najjar, M. F., & Pfeiffer, C. (2005) · PubMed · Cited by 185
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era
Kalantar-Zadeh, K., Höffken, B., Wünsch, H., Fink, H., Kleiner, M., & Luft, F. C. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90649-5 · Cited by 183
Nairz, M., Theurl, I., Ludwiczek, S., Theurl, M., Mair, S. M., Fritsche, G., & Weiss, G. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00942.x · Cited by 182
Vanrenterghem, Y., Bárány, P., Mann, J. F. E., Kerr, P. G., Wilson, J., Baker, N. F., & Gray, S. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00657.x · Cited by 174
Iron management in end-stage renal disease
Fishbane, S., & Maesaka, J. K. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90192-x · Cited by 174
Silverberg, D. S., Iaina, A., Peer, G., Kaplan, E., Levi, B. A., Frank, N., Steinbruch, S., & Blum, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90546-6 · Cited by 173
Fishbane, S., Shapiro, W., Dutka, P., Valenzuela, O. F., & Faubert, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00077.x · Cited by 170
Iron Overload Alters Innate and T Helper Cell Responses to Candida albicans in Mice
Mencacci, A., Cenci, E., Boelaert, J. R., Bucci, P., Mosci, P., d'Ostiani, C. F., Bistoni, F., & Romani, L. (1997) · The Journal of Infectious Diseases · doi:10.1086/516481 · Cited by 169
Terasaki, P. I., & Ozawa, M. (2005) · Transplantation · doi:10.1097/01.tp.0000174338.97313.5a · Cited by 168
The evaluation of iron status in hemodialysis patients.
Fishbane, S., Kowalski, E. A., Imbriano, L. J., & Maesaka, J. K. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122654 · Cited by 167
Hypersensitivity reactions and deaths associated with intravenous iron preparations
Bailie, G. R., Clark, J. A., Lane, C. E., & Lane, P. L. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh820 · Cited by 164
A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia
Macdougall, I. C., Rossert, J., Casadevall, N., Stead, R. B., Duliege, A.-M., Froissart, M., & Eckardt, K.-U. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa074037 · Cited by 158
Benefits of preserving residual renal function in peritoneal dialysis
Marrón, B., Remón, C., Fontán, M. P., Quirós, P., & Ortíz, A. (2008) · Kidney International · doi:10.1038/sj.ki.5002600 · Cited by 157
Macrophage nutriprive antimicrobial mechanisms
Appelberg, R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0206079 · Cited by 156
Anti-Erythropoietin Antibodies and Pure Red Cell Aplasia
Rossert, J., Casadevall, N., & Eckardt, K. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000107561.59698.42 · Cited by 149
On the relative safety of parenteral iron formulations
Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh185 · Cited by 149
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
Harrington, R. A., Becker, R. C., Cannon, C. P., Gutterman, D. D., Lincoff, A. M., Popma, J. J., Steg, P. G., Guyatt, G. H., & Goodman, S. G. (2008) · CHEST Journal · doi:10.1378/chest.08-0691 · Cited by 145
Iron Administration and Clinical Outcomes in Hemodialysis Patients
Feldman, H. I., Santanna, J., Guo, W., Furst, H., Franklin, E., Joffe, M. M., Marcus, S. M., & Faich, G. A. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133734 · Cited by 143
Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study
Verhelst, D., Rossert, J., Casadevall, N., Krüger, A., Eckardt, K., & Macdougall, I. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16302-2 · Cited by 139
Serum Iron Markers Are Inadequate for Guiding Iron Repletion in Chronic Kidney Disease
Ferrari, P., Kulkarni, H., Dheda, S., Betti, S., Harrison, C., Pierre, T. G. S., & Olynyk, J. K. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04190510 · Cited by 138
Mitsnefes, M. M., Kimball, T. R., Kartal, J., Witt, S. A., Glascock, B. J., Khoury, P. R., & Daniels, S. R. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.08.017 · Cited by 136
Suspected iron dextran-related adverse drug events in hemodialysis patients
Fletes, R., Lazarus, J. M., Gage, J. O., & Chertow, G. M. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80123-2 · Cited by 135
Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy
Choukroun, G. J., Kamar, N., Dussol, B., Étienne, I., Cassuto, É., Toupance, O., Glowacki, F., Moulin, B., Lebranchu, Y., Touchard, G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060546 · Cited by 132
Pure red-cell aplasia due to anti-erythropoietin antibodies
Eckardt, K., & Casadevall, N. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg182 · Cited by 131
Canavese, C., Bergamo, D., Ciccone, G., Longo, F., Fop, F., Thea, A., Martina, G., & Piga, A. G. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00480.x · Cited by 130
Charytan, C., Qunibi, W. Y., & Bailie, G. R. (2005) · Nephron Clinical Practice · doi:10.1159/000085049 · Cited by 129
The silent risks of blood transfusion
Rawn, J. D. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32830f1fd1 · Cited by 129
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease
Agarwal, R., Rizkala, A. R., Bastani, B., Kaskas, M. O., Leehey, D. J., & Besarab, A. (2006) · American Journal of Nephrology · doi:10.1159/000096174 · Cited by 127
Diagnosis of iron deficiency in chronic renal failure
Fernández-Rodríguez, A. M., Guindeo-Casasús, M. C., Molero-Labarta, T., Domínguez-Cabrera, C., Hortal-Cascón, L., Pérez-Borges, P., Vega-Díaz, N., Saavedra-Santana, P., & Palop-Cubillo, L. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70079-x · Cited by 126
Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients
Brookhart, M. A., Schneeweiss, S., Avorn, J., Bradbury, B. D., Liu, J., & Winkelmayer, W. C. (2010) · JAMA · doi:10.1001/jama.2010.206 · Cited by 125
The Role of Ascorbic Acid in the Metabolism of Storage Iron
Lipschitz, D. A., Bothwell, T. H., Seftel, H. C., Wapnick, A. A., & Charlton, R. W. (1971) · British Journal of Haematology · doi:10.1111/j.1365-2141.1971.tb07024.x · Cited by 117
Rambod, M., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01070308 · Cited by 116
Morbidity and mortality in children with anemia at initiation of dialysis
Warady, B. A., & Ho, M. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1214-1 · Cited by 110
Attallah, N. M., Osman‐Malik, Y., Frinak, S., & Besarab, A. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.025 · Cited by 110
Fehr, T. H., Ammann, P., Garzoni, D., Korte, W. C., Fierz, W., Rickli, H., & Wuthrich, R. P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00880.x · Cited by 107
Teehan, G. S., Bahdouch, D., Ruthazer, R., Balakrishnan, V. S., Snydman, D. R., & Jaber, B. L. (2004) · Clinical Infectious Diseases · doi:10.1086/382878 · Cited by 103
The effects of ascorbic acid on the intracellular metabolism of iron and ferritin.
Bridges, K. R., & Hoffman, K. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67014-0 · Cited by 101
Anemia in children with chronic kidney disease
Koshy, S. M., & Geary, D. F. (2007) · Pediatric Nephrology · doi:10.1007/s00467-006-0381-2 · Cited by 100
Skali, H., Parving, H., Parfrey, P. S., Burdmann, E. A., Lewis, E. F., Ivanovich, P. T., Keithi-Reddy, S. R., McGill, J. B., McMurray, J. J. V., Singh, A. K., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.030411 · Cited by 94
A study of parenteral iron regimens in hemodialysis patients
Besarab, A., Kaiser, J. W., & Frinak, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70103-4 · Cited by 91
Gaughan, W. J., Liss, K., Dunn, S., Mangold, A. M., Buhsmer, J. P., Michael, B., & Burke, J. F. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90307-3 · Cited by 88
Tessitore, N., Girelli, D., Campostrini, N., Bedogna, V., Solero, G. P., Castagna, A., Melilli, E., Mantovani, W., MATTEIS, G. D., Olivieri, O., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq321 · Cited by 88
Anemia and Risk of Hospitalization in Pediatric Chronic Kidney Disease
Staples, A. O., Wong, C. S., Smith, J. M., Gipson, D. S., Filler, G., Warady, B. A., Martz, K. L., & Greenbaum, L. A. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05301107 · Cited by 83
Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks
Macdougall, I. C. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1087 · Cited by 81
Macdougall, I. C., & Ashenden, M. J. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.12.010 · Cited by 80
Locatelli, F., Baldamus, C. A., Villa, G., Ganea, A., & de Francisco, Á. L. M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33920 · Cited by 79
Johansen, K. L., Finkelstein, F. O., Revicki, D. A., Gitlin, M. D., Evans, C., & Mayne, T. J. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.018 · Cited by 78
Serum ferritin assay and iron status in chronic renal failure and haemodialysis.
Hussein, S., Prìeto, J., O'Shea, M., Hoffbrand, A. V., Baillod, R. A., & Moorhead, J. F. (1975) · BMJ · doi:10.1136/bmj.1.5957.546 · Cited by 78
Cournoyer, D., Toffelmire, E. B., Wells, G. A., Barber, D. L., Barrett, B. J., Delage, R., Forrest, D. L., Gagnon, R. F., Harvey, E. A., Laneuville, P., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000140219.28618.9f · Cited by 78
Shander, A., & Sazama, K. J. (2010) · Transfusion · doi:10.1111/j.1537-2995.2009.02551.x · Cited by 77
Hoen, B., Paul-Dauphin, A., & Kessler, M. (2002) · Clinical Nephrology · doi:10.5414/cnp57457 · Cited by 77
Influence of target hemoglobin in dialysis patients on morbidity and mortality
Collins, A. J. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.9.x · Cited by 76
Erythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients
Foley, R. N., Curtis, B. M., & Parfrey, P. S. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04950908 · Cited by 74
Berns, J. S., Rudnick, M. R., & Cohen, R. M. (1992) · PubMed · Cited by 72
Red cell or serum folate? Results from the National Pathology Alliance benchmarking review: Figure 1
Galloway, M. J., & Rushworth, L. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.12.924 · Cited by 71
Tolman, C., Richardson, D., Bartlett, C., & Will, E. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080688 · Cited by 71
Transfusion-transmitted tick-borne infections: A cornucopia of threats
Leiby, D. A. (2004) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2004.07.001 · Cited by 70
Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease
Lewis, E. F., Pfeffer, M. A., Feng, A., Uno, H., McMurray, J. J. V., Toto, R., Gandra, S. R., Solomon, S. D., Moustafa, M., Macdougall, I. C., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06450710 · Cited by 70
Macdougall, I. C., & Roche, A. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.032 · Cited by 68
Variability of ferritin measurements in chronic kidney disease; implications for iron management
Ford, B. A., Coyne, D. W., Eby, C. S., & Scott, M. G. (2008) · Kidney International · doi:10.1038/ki.2008.526 · Cited by 68
Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients
Eckardt, K., Kim, J. D., Kronenberg, F., Aljama, P., Anker, S. D., Canaud, B., Molemans, B., Stenvinkel, P., Schernthaner, G., Ireland, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101017 · Cited by 68
Gandra, S. R., Finkelstein, F. O., Bennett, A. V., Lewis, E. F., Brazg, T., & Martin, M. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.019 · Cited by 67
Goodkin, D. A., Fuller, D. S., Robinson, B. M., Combe, C., Fluck, R., Mendelssohn, D. C., Akizawa, T., Pisoni, R. L., & Port, F. K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020173 · Cited by 67
Iron Requirements in Hemodialysis
SARGENT, J. A., & Acchiardo, S. R. (2004) · Blood Purification · doi:10.1159/000074931 · Cited by 66
Ascorbic Acid for Anemia Management in Hemodialysis Patients: A Systematic Review and Meta-analysis
Deved, V., Poyah, P. S., James, M. T., Tonelli, M. A., Manns, B., Walsh, M. W., & Hemmelgarn, B. R. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.040 · Cited by 64
Iron therapy in the pediatric hemodialysis population
Brugnara, C., Dahl, N. V., Watkins, S. L., Warady, B. A., Kausz, A., Lerner, G. R., Brewer, E. D., & Chadha, V. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1457-5 · Cited by 63
Singh, H., Reed, J., Noble, S., Cangiano, J. L., & Wyck, D. B. V. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01541005 · Cited by 59
McCarthy, J. T., Regnier, C. E., Loebertmann, C. L., & Bergstralh, E. J. (2000) · American Journal of Nephrology · doi:10.1159/000046199 · Cited by 56
Serum Ferritin in Chronic Kidney Disease: Reconsidering the Upper Limit for Iron Treatment
Fishbane, S. N., Kalantar‐Zadeh, K., & Nissenson, A. R. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17359.x · Cited by 54
Safety of Iron Sucrose in Hemodialysis Patients Intolerant to Other Parenteral Iron Products
Charytan, C., Schwenk, M. H., Al-Saloum, M. M., et al. (2004) · Nephron Clinical Practice · doi:10.1159/000076401 · Cited by 46
Foley, R. N., Curtis, B. M., & Parfrey, P. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02100508 · Cited by 40
Cardiac disease in children with mild-to-moderate chronic kidney disease
Schaefer, F. S. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282fb7bf2 · Cited by 34
Erythropoietin Response to Blood Loss in Hemodialysis Patients is Blunted but Preserved
Ross, R. P., McCrea, J. B., & Besarab, A. (1994) · ASAIO Journal · doi:10.1097/00002480-199407000-00122 · Cited by 33
Serum Ferritin and Bone Marrow Iron in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
Blumberg, A. (1983) · JAMA · doi:10.1001/jama.1983.03340240043027 · Cited by 33
Sheashaa, H., Abdel-Razek, W., El-Husseini, A. A., Selim, A., Hassan, N. M. A. E.-F., Abbas, T. M., El-Askalani, H., & Sobh, M. A. K. (2005) · Nephron Clinical Practice · doi:10.1159/000083891 · Cited by 27
Upper Limit of Serum Ferritin: Misinterpretation of the 2006 KDOQI Anemia Guidelines
Fishbane, S. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00420.x · Cited by 26
Pérgola, P. E., Gartenberg, G. J., Fu, M., Wolfson, M., Rao, S. V., & Bowers, P. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03470509 · Cited by 26
Individualizing Decision-Making—Resurrecting the Doctor-Patient Relationship in the Anemia Debate
Agarwal, R. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02830310 · Cited by 20
Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.
Shahrbanoo, K., & Taziki, O. (2008) · PubMed · Cited by 18
Caramelo, C. A., Albalate, M., Bermejillo, T., Navas, S., Ortíz, A., de Sequera, P., Casado, S., & Carreno, V. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.9.1792 · Cited by 18
Oral versus Intravenous Iron Supplementation in Peritoneal Dialysis Patients
Johnson, D. W., Herzig, K. A., Gissane, R., Campbell, S. B., Hawley, C. M., & Isbel, N. M. (2001) · Peritoneal Dialysis International · doi:10.1177/089686080102103s41 · Cited by 16
Quality of Life in CKD Patients Treated With Erythropoiesis-Stimulating Agents
Parfrey, P. S., & Wish, T. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.014 · Cited by 14
Gobin, J., Cernii, A., McLean, R., Finkelstein, F. O., & Simon, D. B. (2011) · Clinical Drug Investigation · doi:10.1007/bf03256938 · Cited by 5
Cited by
Chronic Kidney Disease Diagnosis and Management: A Review
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019) · JAMA · doi:10.1001/jama.2019.14745 · Cited by 1,811
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage
Carson, J. L., Guyatt, G., Heddle, N. M., Grossman, B. J., Cohn, C. S., Fung, M. K., Gernsheimer, T., Holcomb, J. B., Kaplan, L. J., Katz, L. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.9185 · Cited by 1,113
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
Carrero, J. J., Hecking, M., Chesnaye, N. C., & Jager, K. J. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.181 · Cited by 923
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
Metadata
- Authors
- Woo, K. T., & Chan, C. M.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 80
- Issue
- 5
- Pages
- 553-554
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1926136353
- Cited by
- 412
- References
- 158
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.